ASTELLAS-015K-CL-RA25

Study Sponsor: Astellas

Study Title

A Phase 2 Open-label, Noncomparative, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study

Medicine or Vaccine (generic name)

peficitinib hydrobromide

Sponsor Identification Number

015K-CL-RA25

Trial Registry Identification Number(#'s)

NCT01711814
EudraCT 2011-006021-23

Medical Condition

Rheumatoid Arthritis

Phase

Phase 2

Link to Astellas Study Register

https://www.clinicaltrials.astellas.com/study/015K-CL-RA25

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT01711814

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2011-006021-23

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

February 2020